X
    X
    X
    X

    Dyax Corp. Registered Direct Offering

    Our Business Law lawyers represented Dyax Corp. in its $30,000,000 registered direct offering (RDO) to existing institutional investors. Dyax Corp. is a biopharmaceutical company based in Burlington, Massachusetts, which invented, developed and sells KALBITOR for the treatment of hereditary angiodema (HAE).  

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.